Asia Oceania Journal of Nuclear Medicine and Biology

Asia Oceania Journal of Nuclear Medicine and Biology

Follow up assessment on the first local theranostic intra-cavitary Yttrium-90 citrate colloid irradiation for refractory cystic craniopharyngioma: Is it still a valuable treatment option?

Document Type : Case report

Authors
Nadiah Abd Razak
Pung Choon Ping
Kamalia Kamarulzaman
Siti Zarina Amir Hassan
Department of Nuclear Medicine, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia
10.22038/aojnmb.2025.83694.1594
Abstract
Craniopharyngioma is a rare, benign intracranial tumour that can present with solid, cystic, or mixed solid-cystic characteristics. This case report aims to discuss the follow up assessment of our patient after one year of the irradiation therapy for craniopharyngioma. A 43-year-old male who has underlying refractory cystic craniopharyngioma requiring two-weekly aspirations, complicated with visual impairment and panhypopituitarism, was referred to our department for intra-cavitary irradiation therapy. Initial diagnostic assessment with Tc-99m MAA followed by dose calculation using the Backlund formula were conducted prior to the therapy. The patient received 6.22 mCi (230.14 MBq) of Ytrrium-90 citrate colloid via the Ommaya reservoir to deliver a radiation dose of 300 Gy to the tumour. Positive outcomes were observed as signified by the reduction on the aspirated cystic frequency and volume, tumour volume, improvement on the visual function and stable hormonal level. Despite the complications, the intra-cavitary irradiation therapy has demonstrated a significant and valuable therapeutic option for our patient in the management of refractory cystic craniopharyngioma.
Keywords
Cystic craniopharyngioma
Irradiation therapy
Yttrium-90
follow up
Complication
Subjects
  1. Nothfield DC. Rathke-pouch Tumours. Brain.1957; 80(3): 293-312.
  2. Yaşargil MG, Curcic M, Kis M, Siegenthaler G, Teddy PJ, Roth P. Total removal of craniopharyngiomas. Journal of Neuro-surgery. 1990; 73(1): 3-11.
  3. Fischer EG, Welch K, Shillito J, Winston KR, Tarbell NJ. Long-term effects of conservative surgical procedures combined with radiation therapy. Journal of Neurosurgery. 1990; 73(4); 534-40.
  4. Bartels U, Laperriere N, Bouffet E, James D. Intracystic therapies for cystic cranio-pharyngioma in childhood, Frontiers in Endocrinology Pituitary Endocrinology. 2012; 3(39):1-8.
  5. Derrey S, Blond S, Reyns N, Touzet G, Carpentier P, Gauthier H, et al. Management of cystic craniopharyngiomas with stereotactic endocavitary irradiation using colloidal 186Re: a retrospective study of 48 consecutive patients. Neurosurgery. 2008; 63(6): 1045–1052.
  6. Abd Razak N, Pung CP, Kamarulzaman K, Amir Hassan SZ. First local experience of intra-cavitary Yttrium-90 citrate colloid irradiation via ommaya reservoir for refractory cystic craniopharyngioma: a case report. Journal Nuclear Medicine and Molecular Imaging. 2024; 58(3):129-139.
  7. Pollock BE, Lunsford LD, Kondziolka, D, Levine G, Flickinger AJC. Phosphorus-32 intracavitary irradiation of cystic craniopharyngiomas: current technique and long term results. International Journal of Radiation Oncology, Biology, Physics. 1995; 33(2): 437-46.
  8. Julow JV. Intracystic irradiation for Pituitary. 2013; 16(1): 34-45.
  9. Vanhauwaert D, Hallaert G, Baert E, Van Roost D, Okito JPK, Caemaert J. Treatment of cystic craniopharyngioma by endo-cavitary instillation of Yttrium-90 radioisotope - still a valuable treatment option. Journal of Neurological Surgery Part A: Central European Neurosurgery. 2013; 74(5): 307-12.
  10. Julow J, Backlund EO, Lányi F, Hajda M, Bálint K, Nyáry I, et al. Long-term results and late complications after intracavitary yttrium-90 colloid irradiation of recurrent cystic craniopharyngiomas. Neurosurgery. 2007; 61(2): 288-95.
  11. Varlotto J, DiMaio C, Grassberger C, Tangel M, Mackley H, Pavelic M, et al. Multi-modality management of cranio-pharyngioma: a review of various treatments and their outcomes. Neuro-Oncology Practice. 2015; 3(3):173–187.
Asia Oceania Journal of Nuclear Medicine and Biology
Volume 13, Issue 2
July 2025
Pages 179-184